US-based DiabetOmics Inc, which has set up a facility to manufacture rapid testing kits (including one for saliva-based diabetes monitoring) on Hyderabad’s outskirts at Mupireddipally in Medak district, is planning to raise about $20 million early next year to fund the commercialisation of its products and expansion of its recently commissioned global facility in Hyderabad.